(Richmond, BC) – Advanced Cyclotron Systems, Inc. (ACSI) is pleased to announce that it has sold the first of its newly released TR-FLEX cyclotrons. The new cyclotron will be installed and commissioned at the Institute of Radiopharmaceutical Cancer Research of Helmholtz-Zentrum Dresden – Rossendorf (HZDR) in early 2016.
The Institute of Radiopharmaceutical Cancer Research specializes in the development of new radiopharmaceuticals for cancer diagnosis and therapy, and also produces PET tracers for human use on a daily basis. Prof. Dr. Jörg Steinbach, Director of the Institute anticipates that the upgrade to ACSI’s newest cyclotron will not only meet the current requirements of the facility, but also meet any future growth.
“The new ACSI TR-FLEX cyclotron will allow our facility much greater flexibility for production of radionuclides and for an expanded radionuclide research program,” Prof. Steinbach said. “With the large variable energy range, beam lines and higher current capabilities, this machine provides much more versatility than we have had in the past.”
The TR-FLEX beam output and extended energy range provides optimal parameters for both PET and SPECT radionuclide production. Dr. Alexander Zyuzin, Director of Research and Business Development at ACSI, believes that the TR-FLEX will be a valuable addition to the HZDR facility infrastructure. “The Rossendorf site is one of the leading radiopharmaceutical cancer research institutes in the world, and they have chosen the most modern and versatile cyclotron system,” he explained. “With an energy range that can be optimized for the customer’s specific needs, the TR-FLEX is an excellent match for the radionuclide and cyclotron research and development program HZDR has planned.”
With the same small footprint as the popular TR-24, the cost of not only the cyclotron, but the facility infrastructure is reduced markedly in comparison to a traditional commercial SPECT facility that typically employs 30 MeV cyclotrons. The TR-FLEX will allow universities, research institutes and commercial companies to produce significant amounts of SPECT nuclides in addition to standard PET nuclides using modest capital and operational budgets, an ability that was once not realistically affordable for most customers.
ABOUT ADVANCED CYCLOTRON SYSTEMS, INC.
Advanced Cyclotron Systems, Inc. is a world leader in the design and manufacturing of cyclotrons. With over 25 years of experience and more than 50 cyclotron systems sold, ACSI can provide a wide range of equipment and services worldwide. Its cyclotrons are used for the commercial production and distribution of PET and SPECT nuclides by internationally recognized companies and leading research facilities. ACSI cyclotrons are designed, manufactured and assembled in Richmond, Canada.
For more information about ACSI products please contact:
Email to a Friend:
Return to: Main Blog